Effects of Antibiotics on Gut Microbiota
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The gut microbiota influences essential human functions including digestion, energy metabolism, and inflammation by modulating multiple endocrine, neural, and immune pathways of the host. Its composition and complexity varies markedly across individuals and across different sites of the gut, but provides a certain level of resilience against external perturbation. Short-term antibiotic treatment is able to shift the gut microbiota to long-term alternative dysbiotic states, which may promote the development and aggravation of disease. Common features of post-antibiotic dysbiosis include a loss of taxonomic and functional diversity combined with reduced colonization resistance against invading pathogens, which harbors the danger of antimicrobial resistance. This review summarizes the antibiotic-related changes of the gut microbiota and potential consequences in health and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics (ATB) alter gut microbiota diversity and composition leading to dysbiosis, which may affect effectiveness of ICI.”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
In the citing paper
“16S ribosomal RNA sequencing of gene amplicons of patients' feces revealed that microbiota returns to its baseline within 1-3 months after ATB discontinuation.”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
In the citing paper
“However, some bacteria may take years to fully recover [14,20].”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Cited by
Items 401–500 of 636
Antibiotic Exposure and Cardiovascular Disease Risk: A Nationwide Cohort Study
Park, S. J., Kim, M., Jeong, S., Choi, S., Kim, H. J., Kim, H. J., Song, J., Lee, J., Lee, J., Lee, J. W., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.035888 · Cited by 6
“…In this regard, antibiotic exposure may induce gut dysbiosis, potentially contributing to the development and aggravation of various diseases, including CVD. 38 Antibiotics lead intestinal macrophages to become hyperresponsive to bacterial stimulation, resulting in excessive inflammatory cytokines.”
InfluentialQian, Y., Lin, X., Huang, S., Chen, S., Wei, J., Pu, H., Lin, Y., Zhang, R., Xu, J., Li, J., et al. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c01135 · Cited by 5
Chong, Q., Cheng, M., Cao, Q., He, J., Xiao, M., Li, Y., Wang, Z., Wang, J., Zhang, K., & Gou, H. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02640-25 · Cited by 5
“Furthermore, through intricate host-microbiota interactions, such perturbations can profoundly disrupt core physiological functions including digestive metabolism and immune regulation, ultimately exacerbating disease susceptibility (10–12).”
Marsaux, B., Moens, F., Marzorati, M., & de Wiele, T. V. (2023) · Journal of Fungi · doi:10.3390/jof9090877 · Cited by 6
“Broad-spectrum antibiotics are a primary cause of dysbiosis, inducing critical shifts in colonic microbial composition, concentration, and function [19].”
BackgroundNETosis: mechanisms and antimicrobial strategies
Rai, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816147-0.00002-2 · Cited by 5
Impact of Intensive Care Unit Nutrition on the Microbiome and Patient Outcomes
Serbanescu, M. A., Silva, M. D., & Zaky, A. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2022.10.007 · Cited by 5
Diversity loss from multiple interacting disturbances is regime‐dependent
Lear, L., Inamine, H., Shea, K., & Buckling, A. (2023) · Ecology Letters · doi:10.1111/ele.14325 · Cited by 5
Epidemiology and the microbiome
Foxman, B., Seitz, S. M., & Rothenberg, R. (2016) · Annals of Epidemiology · doi:10.1016/j.annepidem.2016.04.007 · Cited by 5
“For example, a disruption of the microbiome occurs following a short course of antibiotics [25].”
Effects of antibiotics on the anti-tumor efficacy of immune checkpoint inhibitor therapy
Nie, F., Guo, J., Pan, J., Guo, Z., Wang, C., Yan, J., & Ma, W. (2024) · Clinical and Translational Oncology · doi:10.1007/s12094-024-03615-0 · Cited by 4
“ATB treatment, even in the short term, causes microbial diversity loss, called dysbiosis, which can persist for up to several months after the ATB therapy [22, 23].”
Antibiotic-induced gut microbiome remodeling reduces neuroinflammation in traumatic brain injury
Flinn, H., Marshall, A., Holcomb, M., Burke, M., Kara, G., Cruz-Pineda, L., Soriano, S., Treangen, T. J., & Villapol, S. (2026) · Communications Biology · doi:10.1038/s42003-026-09737-1 · Cited by 5
“Despite this decline, neuroin fl ammation and brain injury were reduced, suggesting that the bene fi cial effects of ABX may occur through SCFA-independent mechanisms 58 .”
Gut microbiota and sepsis: mechanisms, clinical correlations, and therapeutic prospects
Yu, J., & Liu, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1793041 · Cited by 4
“…imbalance resulting from vitamin A deficiency, while SCFAs help maintain Antibiotics disrupt the balance of the gut microbiota while eliminating pathogenic bacteria, leading to reduced microbial diversity and upregulation of antibiotic resistance genes, with eects that may persist long-term (28).”
Míguez-Suárez, G., Cardelle‐Cobas, A., Sinisterra-Loaiza, L., Vázquez, B. I., Cepeda, A., & Nebot, C. (2022) · Molecules · doi:10.3390/molecules27051474 · Cited by 4
New approach methodologies (NAMs) to study microbiome–host interactions
Liu, C., Jin, J., & Rietjens, I. M. C. M. (2023) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2023.100406 · Cited by 4
Guideline on the prudent prescription of antibiotics in the dental office
Leroy, R., Bourgeois, J., Verleye, L., Declerck, D., Depuydt, P. O., Eloot, A., Carvalho, J. C., Theugels, W., Cauwels, R. G. E. C., Leprince, J. G., et al. (2020) · doi:10.57598/r332c · Cited by 5
DeCesare, L. A., Xu, T. Q., Saclarides, C., Coughlin, J. M., Chivukula, S. V., Woodfin, A. A., Chan, E. Y., Booker, C., & Jacobson, R. A. (2020) · The American Surgeon · doi:10.1177/0003134820942186 · Cited by 5
Zhang, N., Peng, Y., Zhao, L., He, P., Zhu, J., Liu, Y., Liu, X., Liu, X., Deng, G., Zhang, Z., et al. (2022) · Metabolites · doi:10.3390/metabo12100892 · Cited by 4
“This postantibiotic dysbiosis is usually characterized by a loss of diversity, a loss of certain important taxa, shifts in metabolic capacity and reduced colonization resistance against invading pathogens [44].”
BackgroundAntibiotics, the microbiome and gastrointestinal cancers: A causal interference?
Ramai, D., Salati, M., Pomati, G., Amoroso, C., Facciorusso, A., Botticelli, A., & Ghidini, M. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102315 · Cited by 4
Antibiotic treatment inhibits paclitaxel chemotherapy-induced activity deficits in female mice
Grant, C. V., Jordan, K. R., Seng, M. M., & Pyter, L. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284365 · Cited by 4
“This is consistent with the current knowledge that following an initial reduction in bacterial load, antibiotic-resilient bacterial communities will repopulate the gut community [20].”
Zou, W., Liu, Y., Zhang, W., Lin, B., Shen, W., Li, Y., He, Q., & Jin, J. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2230322 · Cited by 4
The Microbiota Architecture of the Chinchilla Gastrointestinal Tract
Wu, Y., Liu, B., Ma, X., Yang, L., Lu, X., Wang, W., & Li, J. (2024) · Veterinary Sciences · doi:10.3390/vetsci11020058 · Cited by 4
“In healthy chinchilla, the gastrointestinal microbiota play crucial roles in the host’s metabolisms, immune responses, and anti-inflammatory functions, serving as a vital defense barrier against invasive pathogenic microorganisms [1,5,6].”
BackgroundPhysiology of Gut Water Balance and Pathomechanics of Diarrhea
Elsasser, T. H., & Faulkenberg, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-51788-4_9 · Cited by 6
Pinho, A. S., Pereira, R. B., Pereira, M. A. C., Rai, A., Ferreira, L., Martins, M. C. L., & Parreira, P. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404065 · Cited by 5
Ashman, S., & Krishnamurthy, H. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816665-9.00004-4 · Cited by 5
Jahan, D., Peile, E., Sheikh, M. A., Islam, S., Parasnath, S., Sharma, P., Iskandar, K., Dhingra, S., Charan, J., Hardcastle, T. C., et al. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1902304 · Cited by 5
“microbial infections, there is also collateral damage to the microbiota, which has an interdependent positive correlation between host and microbiome, especially the commensal gut microflora [164,165].”
BackgroundEffect of Probiotics/Synbiotics on Postoperative Outcomes in Patients Undergoing Abdominal Surgery
Park, I. J. (2022) · 한국정맥경장영양학회지 · doi:10.15747/acnm.2022.14.1.10 · Cited by 5
The gut microbiome: an overview of current trends and risks for paediatric populations
Sangiuolo, K., Cheng, E., Terala, A., Dubrosa, F., & Milanaik, R. L. (2022) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001186 · Cited by 4
“Antibiotics may lead to selection of resistant pathogens that can adversely affect human health [16], a loss of functional diversity [17] and greater colonization of potentially harmful pathogenic organisms [18].”
BackgroundKalra, S. J. S., Shankar, H., Mansoori, N., & Gupta, D. L. (2022) · Drug Target Insights · doi:10.33393/dti.2022.2520 · Cited by 5
“Use of excessive antibiotics for the treatment of sepsis patients inclines to gut dysbiosis and a state of immune suppression, with subsequent poor outcomes in the later course of hospitalization during sepsis (38).”
BackgroundMiró-González, Á. A., Maldonado-Chaar, S. M., Zambrana-Valenzuela, R., Iglesias-Escabi, I. M., & Arciniegas-Medina, N. J. (2023) · Cureus · doi:10.7759/cureus.33813 · Cited by 4
“Furthermore, it is widely recognized that antibiotics can alter the gut microbiota and promote dysbiosis, which has partly driven therapeutic options like fecal microbiota transplantation (FMT) [8,10,11,12].”
BackgroundInfluentialBestatin as a treatment modality in experimental periodontitis
Kamińska, M., Benedyk‐Machaczka, M., Adamowicz, K., Aliko, A., Drzazga, K., Słysz, K., Bielecka, E., Potempa, J., & Mydel, P. M. (2023) · Journal of Periodontology · doi:10.1002/jper.22-0614 · Cited by 4
Vigeland, M. D., Flåm, S. T., Vigeland, M. D., Espeland, A., Zucknick, M., Wigemyr, M., Bråten, L. C. H., Gjefsen, E., Zwart, J., Storheim, K., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12071217 · Cited by 4
“Loss of bacterial diversity, including certain central species, leads to reduced colonization resistance against invading pathogens and advanced antibiotic resistance, as well as changes in host metabolism [24].”
BackgroundTjhin, V. T., Oda, M., Yamashita, M., Iwaki, T., Fujita, Y., Wakame, K., Inagawa, H., & Soma, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-66081-2 · Cited by 4
An, S., Zhen, Z., Wang, S., Sang, M., & Zhang, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03670-8 · Cited by 3
“Another recent assessment showed that with the increase in the proportion of Bacteroides to Thickwalled Bacteria , microbial diversity decreased by 25%, and the core group decreased from 29 to 12 [60].”
Pocidoni, J. B. N., Schieferdecker, M. E. M., & Campos, A. C. L. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.05.006 · Cited by 5
Rubio‐García, A., Luiken, R. E. C., Marcelino, I., Rossen, J. W. A., van Zeijl, J. H., Wagenaar, J. A., & Zomer, A. (2025) · Animal Microbiome · doi:10.1186/s42523-025-00449-1 · Cited by 3
Rai, A., Newaskar, V., Roy, N., & Guchhait, S. K. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00591d · Cited by 3
Early-Life β-Lactam Exposure and the Developing Microbiome: Clinical Relevance and Controversies
Kundnani, N. R., Sharma, A., Levai, M. C., Marin-Bancila, L., Georgescu, D., Botaş, L., Chiriac, S. D., Valcovici, M. D., & Popa, M.-D. (2026) · Microorganisms · doi:10.3390/microorganisms14020440 · Cited by 4
“Experimental studies demonstrate that loss of these commensals impairs bile acid–mediated colonization resistance and facilitates C. difficile expansion through both metabolic disruption and reduced competitive exclusion [93,98,99].”
Mühlen, S., Heroven, A. K., Elxnat, B., Kahl, S., Pieper, D. H., & Dersch, P. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00057-24 · Cited by 3
“Unfortunately, many antibiotics are known to alter the composition and richness of the microbiota, resulting in dysbiosis, which can be unfavorable for overall health (17, 18).”
BackgroundLee, J., Park, S. J., Park, Y. J., Jeong, S., Song, J., Kim, H. J., Chang, J., Kim, K. H., Kim, J. S., Oh, Y. H., et al. (2024) · Archives of Osteoporosis · doi:10.1007/s11657-024-01438-8 · Cited by 4
“Studies have shown that even short-term exposure to antibiotics, such as 7 days, can cause an imbalance in the gut microbiome [42, 43], and that recovery from antibiotic exposure could take up to 4 years [44] or not recover [45].”
BackgroundHilmi, M., Khati, I., Turpin, A., Andremont, A., Burdet, C., Grall, N., Vidal, J., Bousquet, P., Rousseau, B., & Bihan-Benjamin, C. L. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.07.030 · Cited by 3
Deng, H., Zhou, J., Liu, Z., Huang, L., Gu, Y., Chen, P., & Xiao, H. (2025) · Medical Oncology · doi:10.1007/s12032-024-02591-3 · Cited by 3
“This alteration can change metabolic capabilities, reduce the effectiveness of immune therapy, and affect patient prognosis because of microbiota closely related to immune system [111, 112].”
Xu, Y., Xiao, Y., Ai, C., Huang, Y., Zhou, H., Li, J., & Yuan, J. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105288 · Cited by 3
“…effects of antibiotics on animal performance may stem from the modulation of the gut microbiota, enhancement of the mucosal barrier, regulation of the immune system, inhibition of pathogen colonization, and influence on energy metabolism (Lange et al., 2016; Broom, 2018; Zhu et al., 2021).”
Influence of Antimicrobials on the Gut Microbiota
Chowdhury, G., & Ramamurthy, T. (2020) · Springer eBooks · doi:10.1007/978-981-15-3658-8_3 · Cited by 3
Mehta, D. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.29.004839 · Cited by 3
“The gut microbiota controls essential human functions like digestion, energy metabolism, and inflammation by modifying multiple endocrines, neural, and immune pathways of the host [16].”
BackgroundSleep Disorders and Intestinal Diseases: Ad-vances Based on Intestinal Microbiota
尹, 乐. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.127996 · Cited by 3
Holm, M. K. A., Jørgensen, K. M., Bagge, K., Worning, P., Pedersen, M., Westh, H., Monk, J. M., & Bartels, M. D. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01296-22 · Cited by 3
Genetic Diversity - Recent Advances and Applications
Çalişkan, M., & Aydin, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100913 · Cited by 6
Sexual Pain Disorders, Vestibulodynia, and Recurrent Cystitis: The Evil Trio
Graziottin, A., & Maseroli, E. (2022) · Springer eBooks · doi:10.1007/978-3-031-11701-5_25 · Cited by 7
Mahmud, H., Keenan, J. D., Gonzales, J. M., Schallhorn, J. M., Chan, M. F., Arnold, B. F., Cavallino, V., Lietman, T. M., Doan, T. A., & Seitzman, G. D. (2022) · Trials · doi:10.1186/s13063-022-06948-9 · Cited by 3
“Even in cohorts of healthy patients, virome sequencing showed an expansion of antibiotic-specific resistance genes in the gut microbiome persisting three months after a 1-week course of antibiotics [23, 24].”
BackgroundEffects of Varied Sulfamethazine Dosage and Exposure Durations on Offspring Mice
Wang, H., Dang, D., Zhu, L., Pan, M., Zhu, J., Lu, W., Lu, S., & Zhao, J. (2024) · Microorganisms · doi:10.3390/microorganisms12020381 · Cited by 3
“…infections by inhibiting pathogenic bacteria; however, oral antibiotic therapies can cause a series of side effects on the gut microbiota, including the loss of composition and functional diversity, increasing host susceptibility to enteric pathogens, and promoting the spread of resistance [9,10].”
BackgroundLong-term benefits of EPs® 7630 in patients with acute sinusitis: a real-world cohort study
Tisch, M., Roháč, L., Reineke, T., Burkart, M., & Kostev, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1358879 · Cited by 3
Qin, S., Zhu, Y., Tian, G., Jensen, M. B., Zhang, K., Ding, X., Bai, S., Wang, J., Xuan, Y., & Zeng, Q. (2025) · Poultry Science · doi:10.1016/j.psj.2025.105213 · Cited by 4
“This disruption may have lasting deleterious effects on the host, increasing the risk of pathogen infections and disease (Becattini, et al., 2016; Lange, et al., 2016).”
Human microbiota in dengue infection: A narrative review
Romani, F. E., Luvira, V., Chancharoenthana, W., Albanese, M., Maddaloni, L., Branda, F., D’Amelio, S., Gabrielli, S., Scagnolari, C., Mastroianni, C. M., et al. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107643 · Cited by 3
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy
Vitiello, F., Vivaldi, C., Rimini, M., Prinzi, F. L., Rizzato, M. D., Saborowski, A. L., Antonuzzo, L., Rossari, F., Satake, T., Peeters, F., et al. (2025) · Oncology · doi:10.1159/000546856 · Cited by 5
“Thus, previous antibiotic therapy may influence clinical outcomes in patients treated with ICIs, altering gut microbiome inducing dysbiosis [38], altering the colonization of bacterial species, leading to loss of diversity [26].”
Siawaya, A. C. M., Kamgaing, É. K., Rogombe, S. M., Obiang, T., Massala, E. M., Mbadinga, M. J. V. M., Leboueny, M., Ndjindji, O. M., Nzoghe, A. M., Ondo, J. P., et al. (2019) · Paediatrics and International Child Health · doi:10.1080/20469047.2019.1577063 · Cited by 3
Wpływ mikrobioty jelitowej na występowanie zaburzeń psychicznych oraz chorób neurodegeneracyjnych
Frej−Mądrzak, M., Kołodziej, P., Sarowska, J., & Jama−Kmiecik, A. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2021-0021 · Cited by 3
Zhong, X., Palin, V., Ashcroft, D. M., Goldacre, B. M., MacKenna, B., Mehrkar, A., Bacon, S., Massey, J., Inglesby, P., collaborative, T. O., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03480-2 · Cited by 2
“This scenario may lead to the failure of antibiotic treatments and increased vulnerability to the harmful effects of infections [10, 39].”
BackgroundAntibiotics for Rheumatologic Diseases: A Critical Review
Falagas, M. E., Stathopoulos, P., Kontogiannis, D. S., & Tzvetanova, I. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110527 · Cited by 2
“This suggests that antibiotics altering microflora could either induce or prevent dysbiosis, and might even have a beneficial effect on patients with ongoing autoinflammatory disease [42,43].”
Ziogas, D. C., Theocharopoulos, C., Martinos, A., Lyrarakis, G., Stefanou, D. T., Anastasopoulou, A. N., & Gogas, H. (2026) · Current Oncology Reports · doi:10.1007/s11912-026-01744-z · Cited by 2
“…[ 74], depleting immu - nostimulatory LPS-producing species, downregulating ileal MAdCAM-1, permitting migration of IL-17-producing Tregs into tumors [ 75 ] and upregulating immunosuppressive markers such as PD-L2 and RMGb on immune cells; and (3) perturb lipid and bile acid metabolism [ 76, 77 ].”
Selective Human-Milk-Inspired Antimicrobial Peptides for the Treatment of Bacterial Vaginosis
Shah, I. M., Lebrilla, C. B., German, J. B., & Mills, D. A. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18030371 · Cited by 3
“Indeed, short-term antibiotic treatments inexorably shift the normal microbiota to dysbiotic states, with potential long-term consequences that aggravate disease and alter digestion, energy metabolism, and importantly, immune pathway regulation [4].”
Beucher, G., Charlier, C., & Cazanave, C. (2019) · Sages-Femmes · doi:10.1016/j.sagf.2019.03.007 · Cited by 2
Vaccination as a strategy to overcome antimicrobial resistance: a fresh look on a well-known problem
Стома, И. О. (2023) · Journal Infectology · doi:10.22625/2072-6732-2023-15-1-5-15 · Cited by 2
Valenzuela-Gutiérrez, R., Lago‐Lestón, A., Cicala, F., Hernández-Rodríguez, M., Barón-Sevilla, B., Armuelles-Bernal, C. E., Vargas‐Albores, F., Garibay-Valdéz, E., Gómez-Reyes, R., & Martínez‐Porchas, M. (2023) · Aquaculture International · doi:10.1007/s10499-023-01301-6 · Cited by 2
“However, in studies on dysbiosis caused by antibiotics in the intestine of fish, it has been reported that the Proteobacteria phylum increases and the Firmicutes and Bacteroidetes phyla decrease (He et al. 2017; Kim et al. 2019; Lange et al. 2016).”
Sapoval, N., Tanevski, M., & Treangen, T. J. (2023) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789811286421_0039 · Cited by 3
Yin, Z., Zhu, L. N., Gao, M., Yu, D., Zhang, Z., Zhu, L., & Zhan, X. (2024) · Foods · doi:10.3390/foods13030481 · Cited by 3
“…and SA had Furthermore, PSA and SA can significantly reduce Proteobacteria and may have the ability to inhibit the propagation of harmful bacteria [29]. different intestinal microbial community compositions The results of Spearman correlation analysis suggested that total SCFAs, acetic acid, and…”
BackgroundAnnual variation in the gut microbiota of captive adult spotted seals, Phoca largha
Liu, Y., Gao, X., Cai, Y., Wang, Z., Zhang, Z., Lü, Z., Xing, Y., Luo, J., Zhang, Z., Shi, H., et al. (2024) · Biological Rhythm Research · doi:10.1080/09291016.2024.2321248 · Cited by 2
“These changes are influenced by various factors, including age, diet, use, and genetic alterations (Lange et al. 2016; Hasan and Yang 2019; Beam et al. 2021).”
BackgroundGottwald, J., Balke, J., Stellmacher, J., van Vorst, K., Ghazisaeedi, F., Fulde, M., & Alexiev, U. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202300437 · Cited by 2
Effects of Tanreqing injection on the gut microbiota in healthy volunteers
Li, S., Zhang, W., Liu, S., Zhou, Y., Liu, W., Yuan, W., & He, M. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1428476 · Cited by 2
“Antibiotic treatment reduces the diversity of gut microbiota species, and a loss of species diversity is a common feature of a disturbed gut microbiota (Lange et al., 2016; Ramirez et al., 2020).”
BackgroundMedeleanu, M., Reyna, M. E., Dai, D. L., Winsor, G. L., Brinkman, F. S. L., Verma, R., Nugent, E., Riaz, N., Simons, E., Mandhane, P. J., et al. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2024.1463867 · Cited by 2
Selective Induced Altered Coccidians to Immunize and Prevent Enteritis
Oz, H. S. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/3952534 · Cited by 2
“Antibiotics enter the food chain and are consumed by humans with possible allergic, antibiotic resistance [10] and other yet elusive side effects.”
BackgroundFæces vivos docent: Microbiome intestinal ancien et problématiques médicales contemporaines
Charlier, P., Augias, A., Sansonetti, P. J., Bon, C., Kennedy, S., & Ségurel, L. (2017) · médecine/sciences · doi:10.1051/medsci/20173311016 · Cited by 2
Basu, S., Bhatnagar, N., Santra, S., & Laul, A. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa072 · Cited by 2
Gut-lung cross talk in COVID-19 pathology and fatality rate
El-Ansary, A. K., Balto, H. A. G., & Al‐Hadlaq, S. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90769-9.00037-2 · Cited by 2
“Extensive, and frequently improper, use of antibiotics may lead to the increase in bacterial resistance and disruption of the normal balance of human microbiota, thereby assisting pathogenic bacteria colonization [64,65].”
BackgroundImpact of the Gram-Negative-Selective Inhibitor MAC13243 on In Vitro Simulated Gut Microbiota
Frisinger, F. S., Pirolo, M., Ng, D. Y. K., Mao, X., Nielsen, D. S., & Guardabassi, L. (2022) · Pharmaceuticals · doi:10.3390/ph15060731 · Cited by 2
“This phenomenon, usually referred to as antibiotic-induced dysbiosis, is caused by the proliferation of opportunistic pathogens accompanied by the killing of beneficial bacteria that would otherwise provide protection for the host [2].”
BackgroundHuman Microbiota Impact on the Efficacy of Pharmacological Treatments: A Review
Siraj, M., Siraj, H., Miran, S., & Hussain, F. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-2333-5.ch011 · Cited by 4
Léone, M., Lopez, A., Userovici, C., & Waele, J. J. D. (2021) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2021.100883 · Cited by 2
Baseline microbiome composition impacts resilience to and recovery following antibioticsPreprint
Chen, C., Löber, U., Bartolomaeus, H., Maier, L., Müller, D. N., Wilck, N., Jarquín‐Díaz, V. H., & Forslund, S. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.31.587491 · Cited by 3
“Even brief antibiotic usage, especially in early childhood, can induce lasting changes in the gut microbiome 12 .”
BackgroundEminoğlu, G. (2020) · Sağlık Bilimlerinde Değer · doi:10.33631/duzcesbed.762252 · Cited by 1
Antibiotika-assoziierte Diarrhoe
Lange, K. S., & Stallmach, A. (2022) · coloproctology · doi:10.1007/s00053-022-00652-7 · Cited by 1
Self-citationGu, L., Yu, S., Kong, L., Wang, Q., Wang, S., Geng, M., Chen, G., Zhang, D., Cao, H., Tao, F., et al. (2023) · Environmental Geochemistry and Health · doi:10.1007/s10653-022-01467-7 · Cited by 1
Symbiotic association of gut microbiome in health and diseases at ageing
Mane, S. S., Patel, D. A., & Patil, P. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99334-0.00049-9 · Cited by 1
Ulusan, M., Bireller, E. S., Ertuğrul, B., Kaşarcı, G., Ataş, M. N., Aydemir, L., Ergen, A., & Çakmakoğlu, B. (2023) · Journal of Stomatology Oral and Maxillofacial Surgery · doi:10.1016/j.jormas.2023.101502 · Cited by 1
Antibiotic‐Induced Changes in the Composition of the Gut Microbiome
Abdi, G., Saeid, A., Wani, A. W., & Johar, V. (2023) · Wiley eBooks · doi:10.1002/9781119904786.ch4 · Cited by 1
Tulupov, A. A., Beschastnov, V. V., Shirokova, I. Y., Kovalishena, O. V., & Tyumenkov, Y. O. (2023) · Clinical and Experimental Surgery Petrovsky journal · doi:10.33029/2308-1198-2023-11-3-105-115 · Cited by 1
Edstorp, J., Rossides, M., Ahlqvist, E., Alfredsson, L. S., Askling, J., Giuseppe, D. D., Grill, V., Sørgjerd, E. P., Tuomi, T., Åsvold, B. O., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06302-5 · Cited by 1
Magdelaine, P., Costantini, A., Kamga, P. T., Youkou, C. G. K., Arrondeau, J., Wislez, M., Emile, J., & Leprieur, E. G. (2025) · Translational Lung Cancer Research · doi:10.21037/tlcr-2024-1083 · Cited by 1
Yu, L., Bi, M., & Xie, L. (2025) · Rejuvenation Research · doi:10.1177/15491684251365971 · Cited by 1
Hou, T., Huang, Y., Jiang, J., Song, Y., & Chen, S. (2025) · The Clinical Respiratory Journal · doi:10.1111/crj.70130 · Cited by 1
Prior antibiotic exposure is associated with worse outcomes in adults with COVID-19
McAlister, F. A., Lin, M., Youngson, E. R. E., Lethebe, B. C., & Leslie, M. (2025) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2025.2585984 · Cited by 1
“Others have already shown that healthy adults treated with antibiotics exhibit reduced production of antimicrobial peptides, immunoglobulin (Ig)G1, IgA, and secondary bile acids [2,11].”
Beeck, W. V., Lemos, M. L. P., Niesen, A. M., Finnegan, P., Shih, T. M., Ho, A. J., Rossow, H. A., & Marco, M. L. (2026) · Applied and Environmental Microbiology · doi:10.1128/aem.02312-25 · Cited by 1
“Contrary to our understanding of antibiotic use on the gut microbiome (60, 61), intramammary injection of CB or CH did not result in short (7 days) or long-term effects (55–75 DIM into the next lactation) on the milk or teat skin microbiota.”
Xu, K., Ren, Y., Zhao, S., Ren, Z., Wang, J., Tu, D., He, F., Feng, J., Wu, W. K., Zhong, Q., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03431-0 · Cited by 1
Sima, S., Jeffries, T., Sial, A. W., Sharma, S., Chopra, N., Zhang, F., Hold, G. L., Li, W., Tu, J., Chen, V., et al. (2026) · JOR Spine · doi:10.1002/jsp2.70174 · Cited by 1
“The use of antibiotics and NSAIDs can alter microbial balance, potentially exacerbating inflammatory pathways relevant to LBP [28, 29].”
Čepić, A., Rausch, P., Geese, T., Dempfle, A., Graßl, G. A., & Baines, J. F. (2026) · mSystems · doi:10.1128/msystems.01640-25 · Cited by 1
“Antibiotic-induced disruption of gut microbiota is well-documented, with recovery trajectories varying based on the type of antibiotic, microbiota composition, diet, and other factors (10, 46–50).”
Yu, J., Li, Q., Zou, S., Rong, Y., Zhang, Y., & Chen, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1733373 · Cited by 1
Solatani, F., Mahdavi, S. Z. B., Eskandani, M., Memar, M. Y., Pourbagherian, O., & Mokhtarzadeh, A. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-42840-1 · Cited by 1
Microbial shifts in early life: the pediatric gut microbiome and its role in health and disease
Waghmode, S., Viswanathan, R., Koligudde, V., Umare, P., & Lavania, M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2681763 · Cited by 1
“16 Furthermore, Denève et al. found that exposure to sub-inhibitory concentrations of certain antibiotics can upregulate genes related to C. difficile's colonization factors, enhancing its adherence to cultured cells.”
Gut Microbiota in Elderly’s Health
Bäuerl, C., Selma‐Royo, M., Mera-Balseca, A. G., Collado, M. C., & Pérez‐Martínez, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_163-1 · Cited by 1
Dietary Assessment of Patients Who Form Kidney Stones
Penniston, K. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-16414-4_6 · Cited by 1
El-Dalatony, M. M., El-Sheekh, M. M., & Li, X. (2020) · Springer eBooks · doi:10.1007/978-981-15-4759-1_6 · Cited by 1
Microbiome and Cellular Players in Type 1 Diabetes: From Pathogenesis to Protection
Badal, D., Paul, M., Jacob, N., & Sachdeva, N. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-33946-3_3 · Cited by 2
The Impact of Gut Microbiota on the Immune Response to Vaccination
Bajoria, V., Szczelkun, A., Dinse, T., van Overveld, F. J., & Rijkers, G. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00051-6 · Cited by 1
Metadata
- Authors
- Lange, K., Buerger, M., Stallmach, A., & Bruns, T.
- Affiliations
- Jena University Hospital (DE)
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 34
- Issue
- 3
- Pages
- 260-268
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2320251182
- Cited by
- 607
- References
- 101
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 92 · 2023: 96 · 2022: 99 · 2021: 79 · 2020: 48 · 2019: 46 · 2018: 33 · 2017: 19 · 2016: 7
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- antibiotics, gut microbiota, dysbiosis, colonization resistance, antimicrobial resistance, microbial diversity, host-microbe interactions, energy metabolism, inflammation, disease susceptibility
- MeSH terms
- Gastrointestinal Microbiome, Anti-Bacterial Agents, Humans, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.